2026 International Congress Archives - Page 25 of 208

Barriers and Enablers to Diversity and Inclusion in Movement Disorders Research (BIND-MD)

H. Collins, E. Manoharan, S. Gandhi, A. Zarkali, A. Batla (London, United Kingdom)
Barriers to Disease-Modifying Clinical Trials in Parkinson’s Disease: A Survey of Clinicians and Researchers Involved in Clinical Trials

J A. de Marcaida, K. Kearney, S. Mccarthy, G. Woolery, K. Hespeler, M. Hespeler, S. Dewitte, A. Espay (Vernon, USA)
Basal ganglia and cerebellum involvement in Myelin Oligodendrocyte antibody associated disease (MOGAD) presenting with facial Dystonia and limb Tremer

N. Sinha, A. Ranjan, R. Singh (Patna, India)
Basal Ganglia Germinoma (BGG) Presenting as Hemidystonia

C. Ryan, R. Patel, S. Younes, M. Chintagumpala, N. Gadgil, M. Parnes (Houston, USA)
Basal Ganglia Hypointensity Associated with Glucose Transporter Type 1 Deficiency Syndrome (GLUT1-DS)

C. Jiménez Clopés, Y. Estrella Domínguez, J. Balsa Vázquez, A. Rojo Sebastián (Alcalá de Henares, Madrid, Spain)
Basal Ganglia Lacunar Infarcts and Risk of Mortality and Dementia in Parkinsonism: A Population-Based Study

L. Malfer, F. Onorati, A. Mullan, R. Savica (Rochester, USA)
Basal Ganglia Pathway Recruitment Determines Bidirectional Bradykinesia Modulation by DBS in Humans

P. Navratil, A. Schmidt, H. Eldebakey, N. Rajamani, V. Odekerken, R. de Bie, C. Zhang, K. Kimura, G. Abbas, R. Peach, J. Roothans, J. Volkmann, F. Lange, M. Reich (Wuerzburg, Germany)
Baseline assessment of nigrostriatal integrity via VMAT2 PET in participants with Parkinson’s disease from the BIIB122/DNL151 LUMA Phase 2b study

A. Hone-Blanchet, R. Llorens-Arenas, B. Hersh, O. Mabrouk, J. Dubois, D. Jennings, M. Clarke, A. Wittington, M. Wald, D. Graham, M. Hutchison (Cambridge, USA)
Baseline auditory-perceptual speech ratings predict improvement in voice intensity after group-based speech intervention in Parkinson’s disease

H. Steurer, E. Schalling, E. Franzén, J. Gustafsson, F. Albrecht (Stockholm, Sweden)
Baseline characteristics of fallers versus non-fallers in a remote, decentralized study of Parkinson’s disease

P. Auinger, R. Wilson, C. Roe, A. Ascherio, J. Beck, S. Benvengo, K. Biglan, E. Dorsey, A. Espay, E. Macklin, M. Monje, E. Neto, D. Novak, M. Schwarzschild, S. Sieberts, T. Simuni, C. Tanner, D. Weintraub, R. Schneider (Rochester, USA)